Underrepresentation among participants in clinical trials leads to inaccurate and unbalanced data of drug and device efficacy. Guests Erin Ferranti PhD, MPH, RN, CDCES, FAHA, FPCNA, FAAN and Ellen Thomas MPH, BSN, RN discuss how nurses are posed to increase diversity among populations enrolled in trials.

Episode Resources

Supported by Cytokinetics, Incorporated, and Novartis Pharmaceuticals Corporation.

Topics

  • Health Equity
  • Research and Evidence-Based Practice

Published on

December 17, 2024

Listen on: